• xbxc1

Europe style for Oxytetracycline Oral Tablets - Tilmicosin Oral Solution 10% – Lihua

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We will constantly satisfy our respected customers with our good excellent, superior value and superior assistance due to we're additional experienced and far more hard-working and do it in cost-effective way for Bromhexine Hydrochloride Oral Solution, Iron Dextran Injection Storage, Ivermectin And Albendazole Oral Suspension Uses, Customer pleasure is our main purpose. We welcome you to definitely build business relation with us. For further more information, you should never wait to contact with us.
Europe style for Oxytetracycline Oral Tablets - Tilmicosin Oral Solution 10% – Lihua Detail:

Tilmicosin is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. It has an antibacterial spectrum that is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. and various Gram-positive organisms such as Corynebacterium spp. It is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Cross-resistance between tilmicosin and other macrolide antibiotics has been observed. Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.

Indications

Macrotyl-250 Oral is indicated for the control and treatment of respiratory infections associated with tilmicosin-susceptible micro-organisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus pleuropneumoniae, Actinomyces pyogenes and Mannheimia haemolytica in calves, chickens, turkeys and swine.

Contra-Indications

Hypersensitivity or resistance to tilmicosin.

Concurrent administration of other macrolides or lincosamides.

Administration to animals with an active microbial digestion or to equine or caprine species.

Parenteral administration, especially in porcine species.

Administration to poultry producing eggs for human consumption or to animals intended for breeding purposes.

During pregnancy and lactation, use only after a risk/benefit assessment by a veterinarian.

Side Effects

Occasionally, a transient reduction in water or (artificial) milk intake has been observed upon treatment with tilmicosin.

Administration and Dosage

For oral administration.

Calves : Twice daily, 1 ml per 20 kg body weight via (artificial) milk for 3 – 5 days.

Poultry : 300 ml per 1000 litre drinking water (75 ppm) for 3 days.

Swine : 800 ml per 1000 litre drinking water (200 ppm) for 5 days.

Note: Medicated drinking water or (artificial) milk should be prepared fresh every 24 h. To ensure a correct dosage, the concentration of the product should be adjusted to the actual fluid intake.

Withdrawal Time

- For meat:

Calves : 42 days.

Broilers : 12 days.

Turkeys : 19 days.

Swine : 14 days.

For Veterinary UseOnly , Keep out of reach of children


Product detail pictures:


Related Product Guide:

We insist about the theory of growth of 'High excellent, Performance, Sincerity and Down-to-earth working approach' to offer you with great company of processing for Europe style for Oxytetracycline Oral Tablets - Tilmicosin Oral Solution 10% – Lihua , The product will supply to all over the world, such as: Lithuania, Birmingham, Dubai, Our company adheres to the spirit of "lower costs, higher quality, and making more benefits for our clients". Employing talents from the same line and adhering to the principle of "honesty, good faith, real thing and sincerity", our company hopes to gain common development with clients from both at home and abroad!
  • Previous
  • Next:

  • We feel easy to cooperate with this company, the supplier is very responsible, thanks.There will be more in-depth cooperation.
    5 Stars By Christian from Ukraine - 2017.09.26 12:12
    It's really lucky to find such a professional and responsible manufacturer, the product quality is good and delivery is timely, very nice.
    5 Stars By olivier musset from Algeria - 2018.11.04 10:32